Three core targets (EGFR, PI3K, and MAPK3(ERK)) closely linked to the occurrence and development of breast cancer were chosen for a virtual screening docking simulation study against twenty-four active ingredients of SP in order to further validate the active ingredients and their potential targets and mechanisms in the treatment of BC from SP. The gene discussed is EGFR; the disease is breast carcinoma.